These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11422)

  • 21. Effect of nicotine pretreatment on striatal dopaminergic system in rats.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1989 Jan; 32(1):221-6. PubMed ID: 2734333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.
    Koe BK
    Experientia; 1975 Jun; 31(6):669-71. PubMed ID: 237777
    [No Abstract]   [Full Text] [Related]  

  • 23. Does dopamine play a role in schizophrenia?
    Carlsson A
    Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
    Vaatstra WJ; Eigeman L
    Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The differential effects of amphetamine and methylphenidate on the biosynthesis of [3H]dopa from [3H]tyrosine in mouse striata in vivo.
    Fung YK; Uretsky NJ
    J Pharm Pharmacol; 1982 Aug; 34(8):531-2. PubMed ID: 6126570
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of environmental enrichment on amphetamine-stimulated locomotor activity, dopamine synthesis and dopamine release.
    Bowling SL; Rowlett JK; Bardo MT
    Neuropharmacology; 1993 Sep; 32(9):885-93. PubMed ID: 8232791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat.
    Algeri S; Ponzio F; Dolfini E; Jori A
    Neuroendocrinology; 1976; 22(4):343-51. PubMed ID: 1030500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Fornstedt B; Carlsson A
    Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amineptine: its effect on the dopaminergic system of rats.
    Ponzio F; Achilli G; Garattini S; Perego C; Sacchetti G; Algeri S
    J Pharm Pharmacol; 1986 Apr; 38(4):301-3. PubMed ID: 2872297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
    Besson MJ; Cheramy A; Gauchy C; Musacchio J
    Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
    [No Abstract]   [Full Text] [Related]  

  • 34. Involvement of intraterminal dopamine compartments in the amine release in the cat striatum.
    Leviel V; Guibert B
    Neurosci Lett; 1987 May; 76(2):197-202. PubMed ID: 3587753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
    Ponzio F; Cimino M; Achilli G; Lipartiti M; Perego C; Vantini G; Algeri S
    Life Sci; 1984 May; 34(22):2107-16. PubMed ID: 6145075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
    Seeman P; Grigoriadis D
    Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine.
    Nyback H; Sedvall G
    Pharmacol Ther B; 1976; 2(1):49-63. PubMed ID: 772722
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.